title: European League Against Rheumatism And American Diabetes Association.
abstract: We present EULAR sessions on the latest treatments for rheumatic disease with an infliximab biosimilar, certolizumab pegol, secukinumab, and bimekizumab. We also report on significant developments in diabetes presented at ADA's Scientific Sessions.
authors: Walter
authors: W
authors: Alexander